Ascentage Pharma Reveals Alrizomadlin Data at ASCO 2025
02 Jun 2025 //
GLOBENEWSWIRE
Ascentage Pharma`s Updated Results on Potential of Alrizomadlin + Pembrolizumab
06 Jun 2022 //
PRNEWSWIRE
Ascentage Pharma`s MDM2-p53 Inhibitor APG-115 Granted RPD Designation by FDA
21 Mar 2022 //
PRNEWSWIRE